Jose Orellana
Internal Medicine · Cape Coral, FLNPI 1104845460
Payments from drug & device makers
Across 238 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$552
- Lilly USA, LLC$372
- Sunovion Pharmaceuticals Inc.$346
- Johnson & Johnson$344
- Amarin Pharma, Inc.$245
- Abbott$195
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,103100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$172
- NURTEC ODT$116
How this compares
$4,103 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 72 | $79,454 |
| JanuviaSitagliptin Phosphate | 81 | $62,375 |
| JanumetSitagliptin Phos/Metformin Hcl | 74 | $55,740 |
| EliquisApixaban | 51 | $36,387 |
| LinzessLinaclotide | 48 | $35,151 |
| FarxigaDapagliflozin Propanediol | 44 | $32,481 |
| TradjentaLinagliptin | 42 | $28,377 |
| Tresiba Flextouch U-200Insulin Degludec | 36 | $23,139 |
| MounjaroTirzepatide | 14 | $14,525 |
| VascepaIcosapent Ethyl | 27 | $12,360 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $12,152 |
| MyrbetriqMirabegron | 12 | $6,986 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $6,783 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $2,872 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 110 | $2,848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet, Janumet Xr | $127 | $130,266168 claims |
| Boehringer IngelheimJardiance, Tradjenta | $166 | $107,831114 claims |
| PfizerEliquis | $79 | $36,38751 claims |
| AbbVieLinzess, Synthroid | $552 | $36,12163 claims |
| AstraZenecaFarxiga | $50 | $32,48144 claims |
| Lilly USA, LLCMounjaro | $372 | $14,52514 claims |
| Astellas Pharma US IncMyrbetriq | $52 | $6,98612 claims |
| GSKAnoro Ellipta | $45 | $6,78314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Cape Coral
- Jose Cevallos YepezCape Coral$4.2M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.